Wall Street Analysts See a 319.23% Upside in Janux Therapeutics (JANX): Can the Stock Really Move This High?

Shares of Janux Therapeutics, Inc. (JANX) have gained 1.8% over the past four weeks to close the last trading session at $13.99, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $58.65 indicates a potential upside of 319.2%.The mean estimate comprises 17 short-term price targets with a standard deviation of $34.53. While the lowest estimate of $12.00 indicates a 14.2% decline fro ...